Recent cancer trends in the united states

Journal of the National Cancer Institute

Volumn 87, Issue 3, 1995, Pages 175-182

  Devesa, Susan S ^a   Blot, William J ^a   Stone, B J ^a   Miller, Barry A ^b   Tarone, Robert E ^a   Fraumeni, Joseph F ^a  

^a Division of Cancer Etiology ^*  (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER STATISTICS; SEX DIFFERENCE;

AGE DISTRIBUTION; FEMALE; HUMAN; INCIDENCE; MALE; MODELS, STATISTICAL; NEOPLASMS; RACIAL STOCKS; SEER PROGRAM; SEX DISTRIBUTION; UNITED STATES;

EID: 0028910239     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/87.3.175     Document Type: Article

References (54)

1. Ries LA, Miller BA, Hankey BF, et al, eds: SEER Cancer Statistics Review, 1973–1991: Tables and Graphs. NIH Publ No. 94-2789. Bethesda, Md: NCI, 1994
2. Davis DL, Dinse GE, Hoel DG: Decreasing cardiovascular disease and increasing cancer among whites in the United States from 1973 through 1987. Good news and bad news [see comment citations in Medline]. JAMA 271:431–437, 1994
3. Adami HO, Bergstrom R, Sparen P, et al: Increasing cancer risk in younger birth cohorts in Sweden [see comment citations in Medline]. Lancet 341:773–777, 1993
4. World Health Organization: International Classification of Diseases for Oncology. Geneva: WHO, 1976
5. World Health Organization: Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Ninth revision. Geneva: WHO, 1977
6. Miller BA, Feuer EJ, Hankey BF: Recent incidence trends for breast cancer in women and the relevance of early detection: an update [see comment citation in Medline]. CA Cancer J Clin 43:27–41, 1993
7. Hankey BF, Brinton LA, Kessler LG, et al: Breast. In SEER Cancer Statistics Review: 1973–1990 (Miller BA, Ries LA, Hankey BF, et al, eds). NIH Publ No. 93-2789. Bethesda, Md: NCI, 1993, pp IV.1–IV.24
8. Tarone RE, Chu KC: Implications of birth cohort patterns in interpreting trends in breast cancer rates. J Natl Cancer Inst 84:1402–1410, 1992
9. National Cancer Institute: 1987 Annual Cancer Statistics Review, Including Cancer Trends: 1950–1985. NIH Publ No. 88-2789. Bethesda, Md: NCI, 1988
10. Kelsey JL, ed: Breast cancer. Epidemiol Rev 15:1–263, 1993
11. Glass AG, Hoover RN: Rising incidence of breast cancer relationship to stage and receptor status. J Natl Cancer Inst 82:693–696, 1990
12. Dewailly E, Dodin S, Verreault R, et al: High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst 86:232–234, 1994
13. Krieger N, Wolff MS, Hiatt RA, et al: Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women [see comment citations in Medline]. J Natl Cancer Inst 86:589–599, 1994
14. Potosky AL, Kessler L, Gridley G, et al: Rise in prostatic cancer incidence associated with increased use of transurethral resection [see comment citation in Medline]. J Natl Cancer Inst 82:1624–1628, 1990
15. Miller BA, Hayes RB, Potosky AL, et al: Prostate. In SEER Cancer Statistics Review: 1973–1990 (Miller BA, Ries LA, Hankey BF, et al, eds). NIH Publ No. 93-2789. Bethesda, Md: NCI, 1993, pp XXII.1–XXII.15
16. Mettlin C, Jones GW, Murphy GP: Trends in prostate cancer care in the United States, 1974–1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA Cancer J Clin 43:83–91, 1993
17. Giovannucci E, Rimm EB, Colditz GA, et al: A prospective study of dietary fat and nsk of prostate cancer [see comment citation in Medline]. J Natl Cancer Inst 85:1571–1579, 1993
18. Devesa SS, Blot WJ, Fraumeni JF Jr. Declining lung cancer rales among young men and women in the United States: a cohort analysis [see comment citation in Medline]. J Natl Cancer Inst 81:1568–1571, 1989
19. Devesa SS, Shaw GL, Blot WJ: Changing patterns of lung cancer incidence by histological type. Cancer Epidemiol Biomarkers Prev 1:29–34, 1991
20. Brown CC, Kessler LG: Projections of lung cancer mortality m the United States: 1985-2025. J Natl Cancer Inst 80:43–51, 1988
21. Peto J, Seidman H, Selikoff U: Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer 45:124–135, 1982
22. Tagnon I, Blot WJ, Stroube RB, et al: Mesothelioma associated with the shipbuilding industry in coastal Virginia. Cancer Res 40:3875–3879, 1980
23. Connelly RR, Spirtas R, Myers MH, et al: Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst 78:1053–1060, 1987
24. Hange P, Devesa SS: Quantification of the impact of known risk factors on time trends in non-Hodgkin’s lymphoma incidence. Cancer Res 52(19 Suppl):5566s–5569s, 1992
25. Gail MH, Pluda JM, Rabkin CS, et al: Projections of the incidence of non-Hodgkin’s lymphoma related to acquired immunodeficiency syndrome [see comment citation in Medline]. J Natl Cancer Inst 83:695–701, 1991
26. Biggar RJ: Cancer in acquired immunodeficiency syndrome: an epidemiological assessment. Semin Oncol 17:251–260, 1990
27. Devesa SS, Fears T: Non-Hodgkin’s lymphoma time trends: United States and international data. Cancer Res 52(19 Suppl):5432s–5440s, 1992
28. Ries LA, Zahm SH, Cheson BD: Non-Hodgkin’s lymphoma. In SEER Cancer Statistics Review: 1973-1990 (Miller BA, Ries LA, Hankey BF, et al, eds). NIH Publ No. 93-2789. Bethesda, Md: NCI, 1993, pp XVIII.1–XVIII.24
29. Glass AG, Hoover RN: The emerging epidemic of melanoma and squamous cell skin cancer [see comment citation in Medline]. JAMA 262:2097–2100, 1989
30. van der Esch EP, Muir CS, Nectoux J, et al: Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 47:483–489, 1991
31. McLaughlin JK, Silverman DT, Hsing AW, et al: Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 52:254–257, 1992
32. Finkle WD, McLaughlin JK, Rasgon SA, et al: Increased risk of renal cell cancer among women using diuretics in the United States. Cancer Causes Control 4:555–558, 1993
33. Desmeules M, Mikkelsen T, Mao Y: Increasing incidence of primary malignant brain tumors: influence of diagnostic methods. J Natl Cancer Inst 84:442–445, 1992
34. Miller RW: Childhood leukemia and neonatal exposure to lighting in nurseries. Cancer Causes Control 3:581–582, 1992
35. Devesa SS, Silverman DT, Young JL Jr, et al: Cancer incidence and mortality trends among whites in the United States, 1947–84. J Natl Cancer Inst 79:701–770, 1987
36. Hankey BF, Edwards BK, Ries LA, et al: Problems in cancer surveillance: delineating in situ and invasive bladder cancer [editorial]. J Natl Cancer Inst 83:384–385, 1991
37. Hankey BF, Silverman DT, Kaplan R: Urinary bladder. In SEER Cancer Statistics Review: 1973–1990 (Miller BA, Rıes LA, Hankey BF, et al, eds). NIH Publ No. 93–2789. Bethesda, Md: NCI, 1993, pp XXVI.1–XXVI.17
38. Brown LM, Pottern LM, Hoover RN: Testicular cancer in young men: The search for causes of the epidemic increase in the United States. J Epidemiol Community Health 41:349–354, 1987
39. Feuer EJ, Brown LM, Kaplan RS: Testis. In SEER Cancer Statistics Review: 1973–1990 (Miller BA, Ries LA, Hankey BF, et al, eds). NIH Publ No. 93-2789. Bethesda, Md: NCI, 1993, pp XXIV.1–XXIV.13
40. Ries LA, Schatzkin A, Kaplan R: Colon and rectum. In SEER Cancer Statistics Review: 1973–1990 (Miller BA, Ries LA, Hankey BF, et al, eds). NIH Publ No. 93-2789. Bethesda, Md: NCI, 1993, pp VI.1–VI.22
41. Potter JD, Slattery ML, Bostick RM, et al: Colon cancer a review of the epidemiology. Epidemiol Rev 15:499–545, 1993
42. Chu KC, Tarone RE, Chow WH, et al: Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst 86:997–1006, 1994
43. Winawer SJ, Zauber AG, Ho MN, et al: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup [see comment citation in Medline]. N Engl J Med 329:1977–1981, 1993
44. Young JL Jr, Percy CL, Asire AJ, eds: Surveillance, Epidemiology, and End Results: Incidence and Mortality Data, 1973-77. Natl Cancer Inst Monogr 57:1–1082, 1981
45. Devesa SS, Young JL Jr, Brinton LA, et al: Recent trends in cervix uteri cancer. Cancer 64:2184–2190, 1989
46. Correa P: Human gastric carcinogenesis: a multiStep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52:6735–6740, 1992
47. Blot WJ, McLaughlin JK, Winn DM, et al: Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48:3282–3287, 1988
48. Surgeon General: The Health Consequences of Using Smokeless Tobacco. NIH Publ No. 86-2874. Bethesda, Md: NIH, 1986
49. Macfarlane GJ, Boyle P, Scully C: Oral cancer in Scotland: changing incidence and mortality [see comment citation in Medline]. BMJ 305:1121–1123, 1992
50. Coggon D, Inskip H: Is there an epidemic of cancer? [see comment citation in Medline]. BMJ 308:705–708, 1994
51. Centers for Disease Control: Human Immunodeficiency Virus (HIV) Infection Codes: Official Authorized Addendum ICD-9-CM, effective January 1, 1988. MMWR 36 (No. S-7): 1–24, 1987
52. Percy C, Van Holten V, eds: ICD-O International Classification of Diseases for Oncology. Field Trial Edition. Bethesda, Md: NCI, 1988
53. Clayton D, Schifflers E: Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med 6:469–481, 1987
54. Holford TR: Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 12:425–457, 1991